Schools in England must provide allergy awareness training for all staff for the first time, under new statutory guidance ...
In a significant leap forward for obesity care, Eli Lilly has officially launched a new formulation of its blockbuster drug, Zepbound, consolidating an entire month of treatment into a single, ...
Lilly launches four-dose Zepbound KwikPen in the US. Self-pay starter price begins at $299 per month. Move aims to improve retention in crowded GLP-1 market. Millions of people on GLP-1 weight-loss ...